Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM

Clinical trial NCT05749133 · UNKNOWN

Trial details

NCT number: NCT05749133
Sponsor: XuYan
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Multiple Myeloma, Refractory

Start date: 2023-04-10
Primary completion: 2025-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.